Chronic wounds are a major healthcare challenge around
the world.
The presence of bacterial biofilms, accumulation of reactive oxygen
species (ROS), and persistent inflammation have been identified as
rate-limiting steps in chronic wound healing. Anti-inflammatory drugs,
like naproxen (Npx) and indomethacin (Ind), show poor selectivity
for the COX-2 enzyme, which plays a key role in producing inflammatory
responses. To address these challenges, we have developed conjugates
of Npx and Ind with peptides possessing antibacterial, antibiofilm,
and antioxidant properties along with enhanced selectivity for the
COX-2 enzyme. We have synthesized and characterized peptide conjugates
Npx-YYk, Npx-YYr, Ind-YYk, and Ind-YYr, which were self-assembled
into supramolecular gels. As envisaged, the conjugates and gels showed
high proteolytic stability and selectivity toward the COX-2 enzyme
and potent antibacterial activities (>95% within 12 h) against
Gram-positive
bacteria Staphylococcus aureus, implicated in wound-related
infections, eradication of biofilm (∼80%), and radical scavenging
(>90%) properties. Cell culture studies with mouse fibroblast cells
(L929) and macrophage-like cells (RAW 264.7) showed that gels were
cell proliferative in nature (120% viability), which resulted in faster
and more efficient scratch healing. Treatment with gels led to a significant
decrease in proinflammatory cytokine (TNF-α and IL-6) expressions
and an increase in anti-inflammatory gene (IL-10) expression. The
gels developed in this work show great promise as a topical agent
for chronic wounds or as a coating for medical devices to prevent
medical-device-associated infections.